Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 23 May 2018 Results (n=64) presented at the 114th International Conference of the American Thoracic Society.
- 19 Mar 2018 Status changed from active, no longer recruiting to completed.
- 10 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.